Associate Director, Business Development, Licensing

At Lonza, we are at the forefront of revolutionizing the pharmaceutical, biotechnology, and nutrition sectors through groundbreaking technology and scientific expertise. Founded in 1897 in the Swiss Alps, our journey began with hydroelectricity and C2 chemistry, evolving through nitrogen chemistry and petrochemistry before dedicating ourselves to fine chemistry and biochemistry. This rich history of innovation has positioned us as a global leader and the original Contract Development and Manufacturing Organization (CDMO). We empower our customers, ranging from emerging biotechs to global pharmaceutical giants, to transform their therapeutic discoveries into life-saving and life-enhancing treatments for patients worldwide. Our commitment to pioneering science, smart technology, and lean manufacturing sets the pace in the CDMO industry.

Our technological advancements span a wide array of services, from early development to drug substance and drug product manufacturing. We lead in established and emerging technologies, including mammalian biologics, small molecules, highly potent active pharmaceutical ingredients (APIs), bioconjugates, mRNA, microbial, and cell and gene therapies. This comprehensive suite of capabilities allows us to provide integrated solutions tailored to our customers' complex needs throughout the entire treatment lifecycle. A pivotal moment in our recent history was our role in the global production of raw materials for the Moderna COVID-19 vaccine, showcasing our capacity for rapid response and large-scale manufacturing of critical medicines. We continuously invest in expanding our global network of over 30 sites across five continents and in cutting-edge technologies to address not only current but also future healthcare challenges. Our 'One Lonza' strategy, powered by our unique core competencies, is designed to generate long-term value and solidify our position as the partner of choice for the global biopharma industry in its quest to bring breakthrough innovations to patients in need.